Deal flow slowed — direct investments fell 46% YoY in September — yet capital still concentrates in AI and health care with selective mega-rounds.
Family offices are recalibrating pace, not appetite. Bezos and Schmidt joined a $300M seed for Periodic Labs (AI-driven automated research), while Harbor Health raised $130M led by DFO Management alongside Breyer Capital and Martin Ventures. Meanwhile, opportunistic moves persist: Mitchell Family Office acquired Cos Bar to integrate $695 AI smart mirrors from a related venture, blending retail and tech.
What this signals: risk isn’t retreating, it’s being reframed. Liquidity is conserved for high-conviction theses (AI infrastructure, clinical platforms, tech-enabled consumer) and for control or strategic influence where value creation levers are clearer. The private equity slowdown is opening windows for family offices to act quickly, align investments with multigenerational interests, and embed operating synergies.
Forward-looking: expect continued barbell behavior — fewer, larger checks into AI/biotech platforms, paired with targeted acquisitions where families can deploy domain expertise and governance. Underwriting shifts from momentum to utility: automation of R&D, scalable care models, and real-world revenue paths.
How is your family office balancing slower deal cadence with higher-conviction allocations — and where are you building operating advantages (data, distribution, or governance) to compound beyond capital?
Family offices are recalibrating pace, not appetite. Bezos and Schmidt joined a $300M seed for Periodic Labs (AI-driven automated research), while Harbor Health raised $130M led by DFO Management alongside Breyer Capital and Martin Ventures. Meanwhile, opportunistic moves persist: Mitchell Family Office acquired Cos Bar to integrate $695 AI smart mirrors from a related venture, blending retail and tech.
What this signals: risk isn’t retreating, it’s being reframed. Liquidity is conserved for high-conviction theses (AI infrastructure, clinical platforms, tech-enabled consumer) and for control or strategic influence where value creation levers are clearer. The private equity slowdown is opening windows for family offices to act quickly, align investments with multigenerational interests, and embed operating synergies.
Forward-looking: expect continued barbell behavior — fewer, larger checks into AI/biotech platforms, paired with targeted acquisitions where families can deploy domain expertise and governance. Underwriting shifts from momentum to utility: automation of R&D, scalable care models, and real-world revenue paths.
How is your family office balancing slower deal cadence with higher-conviction allocations — and where are you building operating advantages (data, distribution, or governance) to compound beyond capital?